Another report demonstrated that the treatment of Tg2576 mice (mice overexpressing the AD-related ‘Swedish’ mutant APP) with luteolin resulted in a significant reduction in soluble Aβ and cerebral amyloidosis. The gene discussed is APP; the disease is Alzheimer disease.